Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.

Anticancer research - 1 Apr 2023

Asako Kentaro, Hayama Tamuro, Hashiguchi Yojiro, Miyata Toshiya, Fukushima Yoshihisa, Shimada Ryu, Kaneko Kensuke, Nozawa Keijiro, Matsuda Keiji, Fukagawa Takeo

Abstract excerpt

BACKGROUND/AIM: The clinical significance of many RAS-family mutations in colorectal cancer (CRC) remains unclear. The purpose of this study was to investigate the relationship of RAS mutations on an exon basis (i.e., mutations in KRAS exons 2, 3, and 4 and in NRAS) with clinicopathological features and prognosis in CRC. PATIENTS AND METHODS: We performed a retrospective cohort study of the medical records and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Exons

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 36974804
DOI: 10.21873/anticanres.16306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.PMID 36974804Read ↗

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patientsSemantic proximity Read ↗

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.Semantic proximity Read ↗

Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.Semantic proximity Read ↗

Prognostic Value of KRAS Mutations in Colorectal Cancer PatientsSemantic proximity Read ↗

Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations.Semantic proximity Read ↗

Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.Semantic proximity Read ↗

Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancerSemantic proximity Read ↗

Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk factors and survival of colorectal cancer patients with RAS/BRAF gene mutationsSemantic proximity Read ↗

KRAS Mutation Status as a Prognostic Marker and Predictor of Therapy Response in Colorectal Cancer: an NCDB Analysis.Semantic proximity Read ↗

KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.Semantic proximity Read ↗

Mutation spectra of RAS gene family in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.